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Borrelia hermsii is a blood-borne pathogen transmitted by the argasid tick Ornithodoros hermsi.
Since spirochaete clearance in mice is associated with an IgM-mediated response, an
immunoproteomic analysis was used to identify proteins reactive with IgM. We report that IgM
from both mice and human patients infected with B. hermsii not only reacted with the previously
identified variable membrane proteins but also identified candidate antigens including heat-shock
proteins, an adhesin protein, ABC transporter proteins, flagellar proteins, housekeeping proteins,
an immune evasion protein, and proteins with unknown function. Furthermore, IgM reactivity to
recombinant glycerophosphodiester phosphodiesterase was detected during early spirochaete
infection and prior to a detectable IgG response. Lastly, a conserved hypothetical protein was
produced in Escherichia coli and tested with immune serum against B. hermsii and Borrelia
recurrentis. These results identify a much larger set of immunoreactive proteins, and could help in
the early serodiagnosis of this tick-borne infection.
INTRODUCTION
Relapsing fever spirochaetes in the genus Borrelia are blood-
borne pathogens distributed throughout much of the world
(Barbour & Hayes, 1986; Felsenfeld, 1971; Southern &
Sanford, 1969). The spirochaetes are transmitted by either
ticks or the human body louse, and other than Borrelia
duttonii and Borrelia recurrentis, which are transmitted
between humans (Burgdorfer, 1951; Buxton, 1946), the
mostcommon vertebrate hostsforthespirochaetes aresmall
rodents (Dworkin et al., 2002; Schwan & Piesman, 2002).
During mammalian infection, a family of immunogenic
variable membrane proteins undergo antigenic variation,
allowing for immune evasion, recurrent spirochaetaemia,
and persistence in the blood (Barbour, 1990; Barbour et al.,
2006;Daietal.,2006;Hayesetal.,1988;Restrepoetal.,1992;
Stoenner et al., 1982). Interestingly, each spirochaetaemic
episode is rapidly cleared from the blood by a robust T-cell-
independent response involving expansion of IgM-secreting
B1b and marginal zone B cells (Alugupalli et al., 2003a, b,
2004; Alugupalli, 2008; Barbour, 1990; Barbour & Bundoc,
2001; Belperron et al., 2005; Newman & Johnson, 1984;
Stoenner et al., 1982).
Relapsing fever Borrelia can reach upwards of 10
7
spirochaetes per ml of infected blood (Bryceson et al.,
1970; Coffey & Eveland, 1967), and can be detected by
microscopy. However, detection by microscopy lacks
sensitivity between spirochaetaemic episodes. Glyceropho-
sphodiester phosphodiesterase (GlpQ) has been used as a
diagnostic antigen for infection with relapsing fever
spirochaetes in North America and Africa (Nordstrand
et al., 2007; Porcella et al., 2000; Schwan et al., 1996).
However, in one report 79% of Ethiopian patients infected
with B. recurrentis did not have detectable IgG responses to
recombinant GlpQ (rGlpQ) during early spirochaete
infection as determined by an ELISA (Porcella et al., 2000).
With variable membrane proteins facilitating immune
evasion, and the robust IgM-mediated response during
early infection, understanding the broader antigenic
Abbreviations: GlpQ, glycerophosphodiester phosphodiesterase; rGlpQ,
recombinant glycerophosphodiester phosphodiesterase.
The GenBank/EMBL/DDBJ accession numbers for the nucleotide
sequences for the genes located on B. hermsii plasmids, and whose
sequences have not previously been deposited in the GenBank
database, are FJ446702 (oppAIV) and FJ446703 (hypothetical protein).
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However, little is known about proteins reactive with
IgM in relapsing fever spirochaetes (Anda et al., 1996;
Colombo & Alugupalli, 2008; Connolly et al., 2004). In this
study, protein candidates reactive with IgM were identified
using serum from mice and human patients infected with
Borrelia hermsii. The amino acid identity of Borrelia
orthologues was compared to B. hermsii, and early IgM
responses to rGlpQ were determined using serum samples
from Ethiopian patients that had previously tested negative
to rGlpQ during early spirochaete infection (Porcella et al.,
2000). Furthermore, a hypothetical protein from B. hermsii
was produced and the immunogenicity of this recombinant
protein was tested as a possible diagnostic antigen.
METHODS
Animal inoculation and immune sera collection. Low-passage B.
hermsii DAH isolate was grown in BSK medium containing 12%
rabbit serum (Barbour, 1984; Battisti et al., 2008) to 1.0610
8
spirochaetes ml
21, and used to needle inoculate three mice
intraperitoneally with 1.0610
5 spirochaetes per mouse. Prior to,
and for the first 4 days and the seventh day after inoculation, blood
was obtained, and the spirochaetaemias were quantified by bright-
field microscopy (Schwan et al., 2003). Immune serum collected from
the mice was pooled. All animal handling was in compliance with the
Rocky Mountain Laboratories Animal Care and Use Committee.
Human serum was available from two patients who were infected
with B. hermsii. Serum samples from both patients were collected
within 1 month of the initial spirochaetaemic episode. Serum samples
from patients infected with B. recurrentis were available from a
hospital in Addis Ababa, Ethiopia, as previously described (Porcella et
al., 2000). The acute-phase serum samples were collected shortly after
hospitalization; the convalescent-phase serum samples were collected
8–13 days later. Acute-phase serum samples used in this study had
tested IgG negative to rGlpQ while convalescent-phase samples were
positive (Porcella et al., 2000).
Sample preparation, 2D electrophoresis and 2D immunoblot-
ting. Low-passage (passage seven) B. hermsii DAH was grown in
mBSK medium containing 12% rabbit serum (Barbour, 1984; Battisti
et al., 2008) and harvested when the spirochaetes were at
approximately 1.0610
8 spirochaetes ml
21. For all sample prepara-
tions, spirochaete concentrations were standardized by adjusting each
preparation to OD600 0.2 in 16 PBS containing 5 mM MgCl2, which
is approximately 7.22610
7 spirochaetes ml
21. Samples were then
centrifuged at 9000 g for 15 min at 4 uC, concentrated eightfold with
16 PBS containing 5 mM MgCl2 and Complete Mini EDTA-free
protease inhibitors (following manufacturer’s instructions) (Roche
Diagnostics) to approximately 5.8610
8 spirochaetes ml
21.
The 5.8610
8 spirochaetes were centrifuged at 13000 g for 5 min and
processed through the ReadyPrep Protein Extraction kit (Soluble/
Insoluble) (Bio-Rad), following the manufacturer’s instructions. After
protein extraction, samples were resuspended in 100 ml2 D
Rehydration Sample Buffer 1 (Bio-Rad) containing 2 mM tributyl-
phosphine (TBP) (Bio-Rad) and 0.2% ampholytes (Bio-Rad).
Samples were precipitated using the ReadyPrep 2-D Cleanup kit
(Bio-Rad), following the manufacturer’s instructions.
Soluble and insoluble fractions were resuspended in 200 ml2 D
Rehydration Sample Buffer 1 containing 2 mM TBP and 0.2%
ampholytes, and used to rehydrate 11 cm pH 4–7, pH 5–8, or pH 7–
10 ReadyStrip IPG Strips (Bio-Rad). Rehydration was performed
under active conditions, and IPG strips were focused for a total of
25000 V h using the PROTEAN IEF (Bio-Rad).
IPG strips were equilibrated for 20 min as specified by the
manufacturer (Bio-Rad) with equilibration buffer 1 containing
5 mM TBP. IPG strips were transferred onto 10.5–14% Criterion
Precast Gels (Bio-Rad), electrophoresed, and stained with the
colloidal Coomassie SimplyBlue SafeStain (Invitrogen) or transferred
onto a nitrocellulose membrane using the iBlot Dry Blotting System
(Invitrogen).
Mouse serum samples collected prior to and 7 days after infection,
and immune serum from human patients infected with B. hermsii,
were used to probe 2D immunoblots at a 1:100 dilution in I-Block
blocking reagent (TROPIX). Secondary mAbs were goat anti-mouse
IgM-HRP (Invitrogen) at 1:4000 or goat-anti-human IgM-perox-
idase (Sigma-Aldrich) at 1:20000. Membranes were developed by
chemiluminescence with the ECL Western Blotting Detection Reagent
(GE Healthcare), following the manufacturer’s instructions. Images
from 2D gels and 2D immunoblots were acquired with the GelDoc
(Bio-Rad), and overlaid in order to select IgM-reactive protein spots.
2D gel protein sample preparation for mass spectrometry.
Protein samples of interest were excised from colloidal Coomassie-
stained (Invitrogen) gels using the 1.0, 2.0, or 3.0 mm Harris UniCore
sampling punch tool (Sigma-Aldrich) and placed into a new Ultra
Low Attachment 96-well Costar Plate (Corning Inc.). Gel plugs were
destained, reduced, alkylated, and then rehydrated in 25 mlo f1 0n g
ml
21 sequencing grade trypsin solution (Promega).
After an overnight incubation at 37 uC, supernatants containing
eluted trypsinized peptides were removed and placed into a new Ultra
Low Attachment 96-well Costar Plate. Peptides were further extracted
by adding 5% formic acid (Sigma-Aldrich) and 50% acetonitrile
(ACN) to the gel plugs for 30 min at 37 uC. The solution was
removed and pooled with the supernatants from the overnight
trypsinization and the extraction repeated. Trypsinized peptides were
dried under vacuum (Jouan) and dissolved in 30 ml of 0.1%
trifluoroacetic acid (TFA) (JT Baker).
Peptide samples were desalted with the C18 ZipTips (Millipore),
following the manufacturer’s instructions with minor modifications.
Briefly, ZipTips were conditioned with 90% methanol and 0.1%
TFA, equilibrated with 0.1% TFA, and peptides bound by pipetting.
Peptides were washed with 0.5% acetic acid (Sigma-Aldrich), eluted
into a Thermo-Fast 96-well skirted plate (ABgene House) with 70%
ACN and 1% acetic acid, and dried under vacuum centrifugation for
mass spectrometric analysis.
Mass spectrometry, B. hermsii database search, and basic
local alignment search tool (BLAST) analysis. Identification of
proteins from 2D gels was performed by mass spectrometry, and this
was repeated four separate times. Tryptic digests were analysed by
coupling the Nanomate (Advion BioSciences), an automated chip-
basednano-electrospray interface source, toa quadrupole–time offlight
mass spectrometer, QStarXL MS/MS System (Applied Biosystems/
Sciex). Peptide sequence information was provided by MS/MS.
AnalystQS software (Applied Biosystems/Sciex) was used for data
acquisition. Data processing and database searching were performed
with the MASCOT software (Matrix Science). A protein database was
generated from the genome sequence of B. hermsii DAH and submitted
to MASCOT as a separate database for searching. Generally, MASCOT
ion scores greater than 24 correspond to a probability of 95% or greater
that the peptide match is not a random event.
To determine the amino acid identity of non-variable membrane
proteins, protein BLAST analysis was performed at http://blast.
ncbi.nlm.nih.gov/Blast.cgi. Also, individual variable small proteins
(Vsps) and variable large protein (Vlp) 5 were named according to
J. E. Lopez and others
2642 Microbiology 155BLAST analysis. A BLAST threshold E-value of 1.0610
24 was used to
identify borrelia proteins.
Production of rGlpQ and recombinant BH0238 (rBH0238). B.
hermsii and B. recurrentis glpQ were expressed as previously described
(Porcella et al., 2000; Schwan et al., 2003). Genomic DNA from B.
recurrentis 115 and B. hermsii DAH was used to amplify glpQ. glpQ was
expressedasaHis-taggedfusionproteininthepET-15b(Novagen)and
pET-32a (Stratagene) expression vectors for B. recurrentis and B.
hermsii, respectively, following the manufacturer’s instructions.
bh0238 was expressed using the pBAD/TOPO ThioFusion expression
system following the manufacturer’s instructions (Invitrogen).
Forward and reverse primers used to amplify bh0238 from B. hermsii
DAH genomic DNA were 59-ATGACTAGATTTTTAGTGGAGG-
TTAGCATGAG-39 and 59-TTTTATTGAAAAGAGTACCCATTTA-
TCATCC-39, respectively. PCR amplification consisted of 34 cycles
with a denaturing temperature of 94 uC for 30 s, annealing
temperature of 55 uC for 30 s, and an extension temperature of
72 uC for 2.5 min. After confirming the correct orientation and
nucleotide sequence within the pBAD/TOPO ThioFusion vector
using the Vector NTI software package (Invitrogen), bh0238 was
induced with a final concentration of 0.2% arabinose and purified
using a His-Bind Quick Column (Novagen) following the manu-
facturer’s instructions.
1D SDS-PAGE and 1D immunoblotting. For detecting anti-GlpQ
Abs during early mouse infection, whole-cell lysates of B. hermsii
DAH, 6 mg His-tagged rGlpQ (Schwan et al., 2003), and Escherichia
coli containing the empty shuttle vector were separated by 1D SDS-
PAGE as previously described (Schwan et al., 1989) and transferred to
a nitrocellulose membrane as stated above. Murine immune sera
collected for the first 4 days post-inoculation were used at a dilution
Fig. 1. 2D immunoblots (A–C) and a
Coomassie stained gel (D) of B. hermsii lysate.
Serum samples from three mice infected with
B. hermsii were collected, pooled, and used to
probe immunoblots (A). Serum from patient 1
(B) and patient 2 (C) was collected after B.
hermsii infection. Proteins identified by mass
spectrometry from 2D gels are numbered on
2D immunoblots (A–C). 1D immunoblots
confirmed that murine pre-immune sera (E)
and human serum from an uninfected donor
were negative to B. hermsii whole-cell lysate
(F). Molecular mass standards are shown on
the left.
Borrelia hermsii immunogenic proteins
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IgG responses, goat-anti-mouse IgM-HRP or HRP-recombinant-
Protein A (ZYMED) were used at a 1:4000 dilution.
rBH0238 produced in the pBAD/TOPO ThioFusion system
(Invitrogen) was examined as follows. E. coli harvested prior to and
2 h after induction or B. recurrentis lysate and 2 mg of purified
rBH0238 were separated by SDS-PAGE (Schwan et al., 1989), and
stained with the colloidal Coomassie SimplyBlue SafeStain
(Invitrogen) or transferred onto a nitrocellulose membrane as stated
above. Immunoblots were probed with a monoclonal anti-poly-
histidine peroxidase conjugate (Sigma-Aldrich) at a 1:2000 dilution,
immune serum from mice infected with B. hermsii at a 1:100
dilution, or acute and convalescent serum from Ethiopian patients
infected with B. recurrentis at a 1:500 dilution. The secondary
molecule used was HRP-recombinant-Protein A (ZYMED). In
addition, convalescent-phase serum samples were used to determine
seroconversion rBH0238.
Table 1. IgM-reactive proteins identified by mass spectrometry
Protein annotation Spot NCBI ID Pred MM* MASCOT ion scoreD
Heat-shock proteins
DnaK B1–B4 BH0518 68.7 274–482
HtpG C4 BH0560 71.3 27–71
GroEL D1–D3 BH0649 60.0 150–316
Adhesin
P66 76–78 BH0603 66.0 60–462
ABC transporter proteins
OppAd II D5–D8 BH0329 60.5 39–91
OppAd IV 70–72 FJ446702 20.5 41–191
Nucleoside-binding protein 2–5§ BH0383 37.2 68–85
Zn-binding protein 42, 44 BH0713 29.5 35, 86
Flagellar proteins
Flagellin 14, 19, 20, 21 BH0147 35.5 91–618
Flagellar basal-body rod protein 40 BH0774 28.7 77
Housekeeping proteins
Enolase 6–9, 13 BH0337 47.4 122–341
Cell-division protein FtsZ 10 BH0299 43.6 67
GAPDH|| F1–F4 BH0057 36.2 150–571
GlpQ 24, 31–33 BH0241B 39.0 78–367
Ef-Tu 17, 23, 30 BH0476 43.4 41–375
Fructose-bisphosphate aldolase 27 BH0445 40.0 33–41
Triosephosphate isomerase 45 BH0055 27.7 211
Phosphoglycerate mutase 52, 53 BH0658 28.5 206–323
Variable membrane proteins
Variable large protein 5 26, 28, 34–36, 38, 39 ABF21151 34.8 153–443
Variable large protein C54silD 12§, 13§ ABF82211 35.0 192–288
Variable small protein 3 precursor E1–E11 AAA22967 18.6 167–318
Variable small protein 22 silD E1–E11 ABF82176 23.0 48–77
Variable small protein 6 E1, E2, E4, E5 AAZ94628 23.0 31–86
Variable small protein 8 precursor E1, E3–E5 AAA59225 23.0 61–98
Variable small protein 58 E3 ABE73350 23.0 80
Variable small protein 2 precursor E3–E5 AAF73948 23.0 60–71
Variable tick protein 61–63 AAT99985 21.0 172–291
Immune evasion protein
Factor H-binding protein 68, 69 EF411143 21.6 38–153
Proteins with unknown function
Hypothetical 4 FJ446703 56.7 32
Hypothetical 41, 46, 47, 48 BH0238 30.6 33–369
P93 1, 73, 74 BH0744 96.3 94–98
*Predicted molecular mass given in kDa.
DMASCOT scores given are a low and high range for a respective protein. Scores above 24 are statistically significant with P,0.05.
dOligopeptide permease homologue.
§Protein plug numbers in a 2D gel with an isolelectric focusing range of pH 4–7.
||Glyceraldehyde-3-phosphate dehydrogenase.
Glycerophosphodiester phosphodiesterase.
J. E. Lopez and others
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ELISA as previously described, with minor modifications (Porcella
et al., 2000). Sera from Ethiopian patients infected with B. recurrentis
were available from their acute phase of infection. Immune and
negative control sera were diluted 1:100 in diluent (16 PBS, 5%
horse serum, 0.05% Tween 20, 0.001% dextran sulfate) and tested in
triplicate. IgM binding to rGlpQ was determined using goat-anti-
human IgM-peroxidase (Sigma-Aldrich) at 1:20000 followed by the
addition of a substrate consisting of 50% 2,29-azino-di-(3-ethyl-
benzthiazoline sulfonate). After 30 min incubation, the A405 was
measured with a Labsystems Multiskan Plus microtitre plate reader
(Fisher Scientific). Samples were considered positive if their mean
absorbance was more than three standard deviations above the mean
of negative control serum samples.
RESULTS
Evaluation of mouse and patient serum samples
infected with B. hermsii
All mice inoculated with B. hermsii DAH became
spirochaetaemic within 3 days after injection (data not
shown). IgM from these mice and patients infected with B.
hermsii recognized antigens ranging from 20 to 100 kDa
(Fig. 1A–C), while murine preimmune sera or sera from
uninfected human patients had little reactivity to B. hermsii
whole-cell lysate (Fig. 1E and F).
Protein spot selection for mass spectrometry
Image overlays from 2D electrophoresis gels and 2D
immunoblots probed with immune serum from mice or
humans identified 114 protein candidates for mass spectro-
metry analysis within the isoelectric focusing range of pH 5–
8 (Fig. 1A–D). Vsps, Vlp 5, and the nucleoside-binding
proteins were the only IgM-reactive proteins identified in
pH 4–7 and pH 7–10 2D gels (data not shown), and of these
proteins, Vlp C54silD and the nucleoside-binding protein
were the only additional proteins not identified in the pH
range 5–8(Table1). Also, there were no apparentdifferences
between protein fractions that were tested by 2D electro-
phoresis and immunoblotting.
Table 2. Percentage amino acid identity of Borrelia orthologues compared to B. hermsii
Protein annotation B. burgdorferi B. recurrentis B. duttonii B. turicatae
Heat-shock proteins
DnaK, BH0518 92 96 96 98
HtpG, BH0560 84 87 87 93
GroEL, BH0649 92 95 95 97
Adhesin
P66, BH0603* 55 66 66 79
ABC transporter proteins
OppAD II, BH0329 65 79 79 82
OppAD IV, FJ446702 47 72 72 78
Nucleoside-binding protein, BH0383 48 64 65 75
Zn-binding protein, BH0713 73 91 91 93
Flagellar proteins
Flagellin, BH0147 91 90 90 93
Flagellar basal-body rod protein, BH0774 84 89 89 95
Housekeeping proteins
Enolase, BH0337 90 95 95 96
Cell division protein FtsZ, BH0299 91 97 98 98
GAPDHd, BH0057 92 95 96 97
GlpQ§, BH0241B - 81 82 89
Ef-Tu, BH0476 94 97 97 97
Fructose-bisphosphate aldolase, BH0445 88 93 93 96
Triosephosphate isomerase, BH0055 77 86 86 91
Phosphoglycerate mutase, BH0658 83 90 91 96
Immune evasion protein
Factor H-binding protein, EF411143* – – – 61
Proteins with unknown function
Hypothetical, FJ446703* – 46 47 58
Hypothetical, BH0238* 53 72 73 83
P93, BH0744 49 67 61 74
*Proteins identified as unique within the Borrelia genus.
DOligopeptide permease homologue.
dGlyceraldehyde-3-phosphate dehydrogenase.
§Glycerophosphodiester phosphodiesterase.
Borrelia hermsii immunogenic proteins
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identity of proteins reactive with immune IgM
Proteins identified by mass spectrometry were grouped
into eight categories where, except for Vsps, protein plugs
containing an individual protein are shown (Table 1).
Given that several Vsps were identified within a protein
plug, mapping peptides identified by mass spectrometry to
their respective Vsp confirmed that unique peptides were
identified from each Vsp (data not shown).
While 114 protein samples were analysed by mass spectro-
metry, identifying the same protein in several spots was
common. This could be due to post-translational modifica-
tionsincludinglipidationoftheidentified variablemembrane
proteins and several of the ABC transporter proteins (Bono et
al., 1998; Burman etal., 1990; Kornacki & Oliver, 1998; Shang
et al., 1998). Also, protein binding to residual DNA and RNA
could cause heterogeneous protein migration.
Amino acid alignments of non-variable membrane proteins
indicated the conserved nature of the identified proteins
when compared to B. hermsii (Table 2). Similar to GlpQ and
the factor H/plasminogen-binding protein (FhbA) (Hovis et
al., 2006; Rossmann et al., 2007; Schwan et al., 1996), no
orthologue of hypothetical protein FJ446703 was identified
in Borrelia burgdorferi (Table 2). Additionally, BLAST analysis
identified P66, FhbA, and hypothetical proteins FJ446703
and BH0238 as unique proteins within the genus Borrelia.
Comparisons of IgM-reactive protein candidates
between human patients and mice infected with
B. hermsii
Immunoblot comparisons confirmed similar IgM profiles
in human patients and mice infected with B. hermsii, where
74% of the protein spots were recognized by both human
and mouse serum samples (Fig. 2). In addition, lack of IgM
reactivity to Vlp 5 from human serum samples was likely
due to the expression of other vlps during their infection.
IgM reactivity to rGlpQ during early B. hermsii and
B. recurrentis infection
Murine and human IgM bound to rGlpQ during early
spirochaete infection (Figs 3 and 4). Murine IgM bound to
rGlpQ at the expected molecular mass by the fourth day
after spirochaete infection (Fig. 3A), and prior to detection
of IgG antibodies (Fig. 3B), while preimmune serum was
negative to the antigens tested (Fig. 3C).
Fig. 3. Detection of IgM to rGlpQ during early B. hermsii infection.
Murine IgM reactivity was detected to rGlpQ 4 days after infection
(A), while an IgG response (B) and preimmune serum were
negative to E. coli lysate, rGlpQ and B. hermsii (C). The arrow
indicates the observed molecular mass of native GlpQ, while the
asterisk indicates the molecular mass of rGlpQ. Molecular mass
standards are shown on the left of each immunoblot.
Fig. 2. Venn diagram demonstrating the reactivity of human and
murine IgM against B. hermsii proteins. Most proteins were
recognized by IgM from both human patients and mice.
J. E. Lopez and others
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samples from eight of 15 Ethiopian patients infected with
B. recurrentis (Fig. 4). In addition, these serum samples
were negative when previously tested for IgG responses
against rGlpQ (Porcella et al., 2000).
Expression and immunogenicity of rBH0238
Given the conserved nature of BH0238, its apparent
immunogenicity in B. hermsii, and preliminary data
suggesting that its orthologue is immunogenic in B.
recurrentis (data not shown), this gene was expressed as a
potential diagnostic antigen. Inducing transformed E. coli
with a final concentration of 0.2% arabinose produced a
protein band at the expected molecular mass of 48 kDa
(Fig. 5A). Immunoblotting with an anti-polyhistidine mAb
confirmed reactivity with a protein at 48 kDa and 35 kDa,
suggesting degradation of rBH0238 (Fig. 5B). In addition,
there was no mAb reactivity in uninduced E. coli (Fig. 5B).
Immunoblotting confirmed the immunogenicity of
rBH0238 in mice (Fig. 6A). Convalescent serum from
Ethiopian patients infected with B. recurrentis reacted with
rBH0238 while their acute serum did not (Fig. 6B).
Reactivity to a protein at approximately 37 kDa in acute
serum samples 1A and 4A suggests reactivity to the
immunogenic protein flagellin (Fig. 6B) (Barbour et al.,
1986, 2008; Coleman & Benach, 1989; Collins & Peltz,
1991; Schneider et al., 1992).
DISCUSSION
The results reported here are from the first comprehensive
identification of B. hermsii protein candidates that are
bound by immune IgM. Furthermore, identifying the
previously reported immunogenic proteins GlpQ, FhbA,
flagellin, Vtp, Vsps and Vlps (Barbour et al., 1986;
Colombo & Alugupalli, 2008; Hovis et al., 2006; Porcella
et al., 2000; Schwan et al., 1996; Shang et al., 1998)
suggested that 2D electrophoresis and immunoblotting was
an adequate method for identifying protein candidates that
are reactive with IgM. In addition, while P66, DnaK, P93
and GAPDH (glyceraldehyde-3-phosphate dehydrogenase)
are reactive with serum generated against B. burgdorferi
(Anda et al., 1994, 1996; Bunikis et al., 1996, 1998;
Coleman & Benach, 1992), we report that these proteins
are also immunogenic during B. hermsii infection.
Interestingly, in B. burgdorferi, DnaK, P93 and GAPDH
are detected by the same IgM monoclonal antibody (Anda
et al., 1994, 1996); however, it is unknown if these proteins
were identified in this study due to a common epitope.
Of the immunoreactive protein candidates identified, heat-
shock, ABC transporter and housekeeping proteins have
been reported as immunostimulators in other organisms
(Bercic et al., 2008; Brown et al., 2001; Bunk et al., 2008;
Da’dara et al., 2008; Delvecchio et al., 2006; Garmory &
Titball, 2004; Granato et al., 2004; Harland et al., 2007;
Jomaa et al., 2005; Lewthwaite et al., 2002, 2001, 2007;
Fig. 4. An ELISA measuring IgM binding to rGlpQ using acute-phase serum samples from 15 Ethiopian patients infected with
B. recurrentis. The standard deviation of each mean is indicated with error bars, and the horizontal line represents the threshold
for determining a positive sample with a P¡0.003.
Borrelia hermsii immunogenic proteins
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2006; Tanabe et al., 2006; Tanghe et al., 1999). For
example, the adjuvant properties of DnaK aid in protecting
against Schistosoma japonicum infection when delivered as
a DNA-based vaccine (Da’dara et al., 2008). The protective
capacity of ABC transporter proteins is observed in mice,
animals immunized with OppA being more resistant to
Yersinia pestis infection compared to control mice (Tanabe
et al., 2006). While the surface localization of various heat-
shock, ABC transporter and housekeeping proteins has
been determined in other bacteria (Balasubramanian et al.,
2008; Delepelaire, 2004; Frisk et al., 1998; Frisk &
Lagergard, 1998; Huesca et al., 1996; Lewthwaite et al.,
1998, 2002, 2001, 2007; Ratnakar et al., 1996; Yamaguchi et
al., 1996), our attempts to confirm surface localization of
these proteins were inconclusive.
An additional objective of our study was to determine early
IgM reactivity to rGlpQ (Porcella et al., 2000). In mice,
IgM reactivity to rGlpQ was detected within 4 days of
spirochaete infection. Furthermore, IgM responses to
rGlpQ were detected from eight additional patients
infected with B. recurrentis. While promising, these results
also suggest the importance of identifying additional
immunogens for early detection of relapsing fever spir-
ochaetes, especially for infections where the organisms are
below the level of detection.
Fig. 5. Production of rBH0238. Coomassie-stained gel (A) and
an immunoblot (B) probed with an anti-polyhistidine mAb of
uninduced and induced E. coli. The arrowheads indicate protein
bands of the expected size for rBH0238.
Fig. 6. Serum reactivity against rBH0238 using serum samples from mice infected with B. hermsii (A) or from patients infected
with B. recurrentis (B). Immunoblots were probed with acute-phase serum samples (labelled A under B. recurrentis
immunoblots) or with convalescent-phase serum samples (labelled C). Molecular mass standards (kDa) are shown next to each
immunoblot.
J. E. Lopez and others
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et al., 2006), and hypothetical proteins FJ446703 and
BH0238. The factor H-binding protein and hypothetical
protein FJ446703 could be diagnostic antigens in North
America because they discriminate between relapsing fever
spirochaetes and Lyme-disease-causing spirochaetes. While
rBH0238 was recognized with serum from patients infected
with B. recurrentis, studies indicate that patients with Lyme
disease also seroconvert to this antigen (data not shown),
limiting rBH0238 as an antigen that could discriminate
between the two species of Borrelia. However, given this
protein’s immunogenicity and BLAST analysis indicating
that it is a Borrelia-specific protein, combining rBH0238
with additional immunogens may aid in diagnosing
infection of relapsing fever spirochaetes.
Two factors complicating the treatment of relapsing fever
patients include high spirochaete counts associated with a
poorer prognosis (Melkert, 1991) and the reported
misdiagnosis of relapsing fever Borrelia (Nordstrand et al.,
2007). Collectively, the data reported here identify proteins
whose immunogenic properties can be further investigated
and may be useful for early serodiagnosis. In addition,
these findings may aid in managing relapsing fever Borrelia
in endemic regions and have the potential to alleviate
healthcare costs in developing countries.
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